Integrated omics reveals actionable drivers of bioactive variation in US milk

Cheng-En Tan; Mariana Barboza; Pagkratios Tagkopoulos; Shanghyeon Kim; Lukas Maximilian Masopust; Ivor Prado; Muhammad Adil Salim; Fangzhou Li; George Berdovskiy; Ilias Apostolakos; Brandon Invergo; Karen M. Kalanetra; Danielle G. Lemay; David A. Mills; Armin Oloumi; Cheng-Yu Weng; Carlito B. Lebrilla; Xuan He; Carolyn Slupsky; Oliver Fiehn; Ibuki Kusumoto; Ameer Y. Taha; Yu Wang; Daniela Barile; Alexis Davis; David E. Olson; Justin B. Siegel; Ilias Tagkopoulos

arXiv · 2610.04970

Integrated omics reveals actionable drivers of bioactive variation in US milk

View original source ↗Read source document ↗Export metadata ↓

Abstract

Despite milk being a global dietary staple, the molecular basis of its health-relevant bioactivity and the factors governing fine-scale compositional variation remain poorly understood. Here, we present an integrated seven-layer omics characterization of 60 US retail milk samples from ten geographic regions, combining genomics, transcriptomics, peptidomics, proteomics, lipidomics, metabolomics, and glycomics on the same samples. We also organized the identified and quantified compounds into the Dairy Molecule Database (DMD), a web-accessible resource for linking milk compound concentrations with SNPs, miRNAs, and product-level factors to support future milk quality optimization. In total, we identified 6,714 compounds and quantified 5,288 with absolute concentrations, including 5,220 compounds not previously available with absolute concentration estimates in existing milk compound databases. These profiles enabled bioactivity efficacy estimation and association analyses of factors linked to milk compound variation. We tested 54 computationally predicted antimicrobial candidate peptides; 35 showed activity and 6 had IC50 values below 256 μg/mL against A. baumannii, an ESKAPE pathogen. We further identified associations between downstream bioactive compound concentrations or estimated bioactivity efficacy and product-level factors, including purchase region, purchase ambient temperature, and packaging opacity, as well as SNPs, estimated Jersey breed proportion, and miRNA abundance. Overall, bioactivity efficacy profiles were associated with purchase region, selected SNPs, Jersey breed proportion, and selected miRNAs. These findings suggest that selective breeding and supply-chain optimization could help improve the bioactive quality of commercial milk.

Explore related subjects

q-bio.QM

Keep this discovery

Explore connections, maps & timelines

BibTeX RIS

Cheng-En Tan, Mariana Barboza, Pagkratios Tagkopoulos, Shanghyeon Kim, Lukas Maximilian Masopust, Ivor Prado, Muhammad Adil Salim, Fangzhou Li, George Berdovskiy, Ilias Apostolakos, Brandon Invergo, Karen M. Kalanetra, Danielle G. Lemay, David A. Mills, Armin Oloumi, Cheng-Yu Weng, Carlito B. Lebrilla, Xuan He, Carolyn Slupsky, Oliver Fiehn, Ibuki Kusumoto, Ameer Y. Taha, Yu Wang, Daniela Barile, Alexis Davis, David E. Olson, Justin B. Siegel, Ilias Tagkopoulos. 2026-10-04. Integrated omics reveals actionable drivers of bioactive variation in US milk. https://arxiv.org/abs/2610.04970

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related papers

arXiv2026

Commutative Algebra Modeling of Mutation and Disease Association

Genetic mutations can lead to disease by disrupting molecular interactions, altering protein stability, inducing misfolding, and promoting protein aggregation. Although existing predictive models have achieved promising performance, they often lack mechanistic interpretability and fail to fully incorporate the underlying physical and chemical principles governing mutation-induced effects. Moreover, current approaches typically address disease association, protein stability changes, and solubility alterations as separate prediction tasks rather than integrating them within a unified framework. In this study, we introduce a multiscale commutative algebra modeling framework for predicting disease-mutation association. Leveraging persistent Stanley-Reisner theory, we extract algebraic invariants to build two predictive models: Commutative Algebra Neural Network (CANet) and Commutative Algebra Gradient Boosting Tree (CATree). The proposed framework is applied to three biologically connected tasks: disease-associated mutation identification, mutation-induced protein stability change prediction, and mutation-induced protein solubility change classification. Across six benchmark tasks, CANet and CATree consistently achieve leading predictive performance, with up to 7.5% relative improvement over existing methods. These results demonstrate that commutative algebra provides a unified, interpretable, and generalizable modeling strategy for mutation-disease association prediction.

q-bio.QM↗

arXiv2026

scTREAT: Latent Diffusion for Single-Cell Drug-Response Prediction

Generating drug-induced transcriptional responses requires a model to account for cellular background together with molecular identity and dose. We present scTREAT, the first diffusion framework to factorize state and drug guidance for single-cell drug-response prediction. A shared latent expression space connects baseline and response, while Guided Decomposable Attention (GD-Attn) injects a baseline representation and a dose-conditioned molecular embedding. Independent channel dropout exposes four conditioning states during training; inference combines three conditional predictions with separately specified state and drug coefficients, and dose modulates drug-guidance strength. On condition-level pseudobulk profiles derived from the Tahoe-100M single-cell atlas, scTREAT achieves the best value on 10 of 12 metrics for unseen cell line-drug combinations (UC) and 11 of 12 for unseen drugs (UD). Ablations examine condition injection, molecular representation, and guidance design. On UD, the relative gains over the second-best model reach 36.11% and 34.21% for DEG logFC-Spearman and logFC-Pearson. These results demonstrate the effectiveness of combining shared latent expression modeling with explicit state and drug conditioning for response prediction.

q-bio.QM↗

arXiv2026

Multiscale MIGHT: Modeling Local and Systemic Particle Transport in the Cardiovascular System

Analytical models of signaling molecule (SM) transport in the cardiovascular system (CVS) force a choice between whole-body scope and vessel-level resolution: Pharmacokinetic models for systemic transport lump each organ and lack small-scale structure, whereas synthetic molecular communication (MC) channel models resolve branched vessel networks (VNs) only for a single pass or capture recirculation only in topologically simple loops, and only partially include SM degradation. To close this gap, we propose Multiscale MIGHT, an extension of the Mixture of Inverse Gaussians for Hemodynamic Transport (MIGHT) model that jointly captures branched topologies, closed-loop circulation, organ clearance, and chemical degradation of SMs. First, we connect the ends of a branched VN to form a closed loop with local and global SM degradation, model the closed-loop channel impulse response for arbitrary transmitter (Tx) and receiver (Rx) positions as a Laplace-domain feedback system, and approximate it in closed form by an inverse Gaussian mixture over multi-pass trajectories. The model is validated against finite-element simulations in COMSOL. Second, we set up a whole-body model, where an exemplary local VN, resolved at vessel-level detail, is embedded into the remaining systemic circulation, represented by lumped organ blocks. We simulate whole-body SM transport for various Tx sites and SM species. Our results show that, at an Rx in a local VN, only the initial pass produces a distinct peak in the SM concentration, significantly shaped by the local vasculature in case of small Tx-Rx distances; subsequent passes arrive strongly dispersed and are shaped almost entirely by organ clearance and chemical degradation rather than by the local VN topology.

q-bio.QM↗